首页> 外文会议>Nanotechnology 2009 : Technical proceedings >Microparticles on the Basis of Segmented Polyurethanes for the Treatment of Tuberculosis
【24h】

Microparticles on the Basis of Segmented Polyurethanes for the Treatment of Tuberculosis

机译:基于分段聚氨酯的微粒治疗肺结核

获取原文
获取原文并翻译 | 示例

摘要

The objective of the research is to develop a new drug delivery system based on polyurethane (PU) microparticles for the treatment of tuberculosis by pulmonary administration to the lungs. The synthesis and characterization of polyurethane microcapsules are studied making use three molecular weight polyethylene glycol (PEG) and tolylene-2,4-diisocyanate (TDI). Antitubercular drugs such as isoniazid was incorporated into the polyurethane microcapsules. The effects of nature and concentration of drug and diols were studied by electronic microscope and size distribution by dynamic light scattering analysis. It was shown that the size of microcapsules at maximum distribution band increases also with the PEG length. The size of polymeric microcapsules and size distribution are important factors for their application for pulmonary administration of drug by respiratory way. The size of microparticles is limited to 1-10 μm. Particles of such size are mainly to be placed in the periphery of the lung and must be phagocytized by alveolar macrophages, the primary site of tuberculosis infection.
机译:该研究的目的是开发一种基于聚氨酯(PU)微粒的新型药物输送系统,用于通过对肺部进行肺部治疗来治疗肺结核。利用三种分子量的聚乙二醇(PEG)和甲苯-2,4-二异氰酸酯(TDI)对聚氨酯微胶囊的合成和表征进行了研究。将抗异位药物如异烟肼掺入聚氨酯微胶囊中。通过电子显微镜研究了药物和二醇的性质和浓度的影响,并通过动态光散射分析研究了其大小分布。结果表明,在最大分配带处的微胶囊的尺寸也随着PEG的长度而增加。聚合物微胶囊的尺寸和尺寸分布是它们通过呼吸方式用于肺部给药的重要因素。微粒的尺寸被限制为1-10μm。这种大小的颗粒主要放置在肺部外围,必须通过肺泡巨噬细胞(结核感染的主要部位)吞噬。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号